EIP
DVAX

Ellis Investment Partners’s Dynavax Technologies DVAX Stock Holding History

Ellis Investment Partners’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-200
Closed -$2K – 340
2022
Q3 		$2K Hold
200
– – ﹤0.01% 721
2022
Q2 		$2K Hold
200
– – ﹤0.01% 724
2022
Q1 		$2K Hold
200
– – ﹤0.01% 749
2021
Q4 		$2K Hold
200
– – ﹤0.01% 750
2021
Q3 		$3K Buy
+200
New +$2.66K ﹤0.01% 712

Other funds holding DVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Ellis Investment Partners's DVAX Position: Q4 2022 in Review

Ellis Investment Partners sold out of Dynavax Technologies (DVAX) in Q4 2022, closing a stake of 200 shares — an estimated $2K sold.

Ellis Investment Partners first reported a position in DVAX in Q3 2021 and held it in 5 quarters. The position peaked at $3K in Q3 2021. 230 funds tracked by Wall St. Rank hold DVAX as of Q4 2022.

  • Ellis Investment Partners reported no remaining Dynavax Technologies position as of Q4 2022 after selling out during the quarter.
  • Ellis Investment Partners sold 200 Dynavax Technologies shares in Q4 2022, an estimated $2K.
  • Ellis Investment Partners first reported a position in Dynavax Technologies in Q3 2021 and held it in 5 quarters.
  • Ellis Investment Partners's Dynavax Technologies position peaked at $3K in Q3 2021.
  • 230 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.